Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial

: Rantalaiho VM, Kautiainen H, Korpela M, Hannonen PJ, Leirisalo-Repo M, Mottonen T

Publisher: BMJ PUBLISHING GROUP

: 2013

: Annals of the Rheumatic Diseases

: ANNALS OF THE RHEUMATIC DISEASES

: ANN RHEUM DIS

: 5

: 72

: 5

: 786

: 788

: 3

: 0003-4967